James E. Tisdale, PharmD

Key Publications

Yang M, Zhang L, Kote A, Fisher C, Tisdale JE, Chen Z, Everett IV TH 4th, Liu X, Chen PS. Sex-dependent activation of apamin-sensitive small-conductance Ca²⁺-activated K⁺ current by ß-1 adrenoceptor stimulation in rabbit ventricles. J Physiol 2026;March 31:doi: 10.1113/JP291047. Online ahead of print.

Alhurayri F, Younis IR, Jalal SI, Logan TF, Maniar R, Bray SM, Quinney SK, Desta Z, Skaar TC, Tisdale JE, Shugg T. Pharmacokinetic drug-drug interaction potential of oral anticancer drugs. Clin Pharmacol Ther 2026;119:1614-1627.

Zhang L, Li X, Andersson T, Kote A, Yang M, Lee PT, Tisdale JE, Chen Z, Everett IV TH, Fishbein MC, Goldhaber JI, Chen PS, Liu X. A female-specific rabbit model of heart failure with preserved ejection fraction. Heart Rhythm2026;23:E476-E485.

Tisdale JE, Jaynes HA, Overholser BR, Sowinski KM, Kovacs RJ. Dihydrotestosterone pretreatment diminishes the severity of drug-induced torsades de pointes. J Cardiovasc Pharmacol 2025;86:343-349.

Lin S, Kote A, Andersson T, Goldhaber JI, Tisdale JE, Li X, Chen PS, Liu X. Using clonidine for neuromodulation in patients with postural orthostatic tachycardia syndrome. Heart Rhythm 2025;22:E781-E790.

Carpenter JS, Jaynes HA, Alzahrani M, Chen PS, Kovacs RJ, Tisdale JE. Palpitations in midlife women: the Menopause Racing Heart Pilot Study. Menopause 2025;32:571-582.

Aboshady OA, Raffa JZ, Quinney SK, Tisdale JE, Overholser BR. QTc interval changes in preeclampsia versus normal pregnancy: a systematic review and meta-analysis. Clin Pharmacol Ther 2025;117:1650-1660.

Liu X, Sung YL, Zhang L, Guo S, Yang M, Tisdale JE, Chen Z, Goldhaber JI, Rubart M, Li X, Chen PS. Antiarrhythmic effects of mirabegron on ventricular fibrillation in Langendorff-perfused rabbit ventricles. J Physiol 2025; 603.9:2533-2549.

Alhurayri F, Jaynes HA, Overholser BR, Sowinski KM, Kovacs RJ, Tisdale JE. Drug-induced increase in dispersion of ventricular repolarization in patients with heart failure with preserved ejection fraction. Int J Cardiol 2025;418:132631.

Huang CY, Overholser B, Sowinski KM, Jaynes HA, Kovacs J, Tisdale JE. Arrhythmias in patients with heart failure prescribed dofetilide or sotalol. JACC Advances 2024;11:101354. 

Huang CY, Overholser BR, Sowinski KM, Jaynes HA, Kovacs RJ, Tisdale JE. Drug-induced QT interval prolongation in patients with heart failure with preserved ejection fraction. PLoS One 2024;19(8): e0308999.

Batra AS, Silka MJ, Borquez A, Cuneo B, Dechert B, Jaeggi E, Kannankeril PJ, Tabulov C, Tisdale JE, Wolfe D; on behalf of the American Heart Association Clinical Pharmacology Committee of the Council on Clinical Cardiology, Council on Basic Cardiovascular Sciences, Council on Cardiovascular Nursing, Council on Genomic and Precision Medicine, and Council on Lifelong Congenital Heart Disease and Heart Health in the Young. Pharmacological management of cardiac arrhythmias in the fetal and neonatal periods. A Scientific Statement from the American Heart Association. Circulation 2024;149:e937-e952.

Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EM, Deswal A, Eckhardt L, Goldberger ZD, Gopinathannair R, Gorenek B, Hess PL, Hlatky M, Hogan G, Ibeh C, Indik J, Kido K, Kusumoto F, Link MS, Linta KT, Marcus GM, McCarthy PM, Patel N, Patton KK, Perez MV, Piccini JP, Russo AM, Sanders P, Streur MM, Thomas KL, Times S, Tisdale JE, Valente AM, Van Wagoner DR. 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation; a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2024;149:e1-e156.

Carpenter JS, Fagan R, Alzahrani M, Jaynes HA, Tisdale JE, Kovacs RJ, Chen CX, Draucker CB.  ‘‘Quick flutter skip;’’ midlife women’s descriptions of palpitations. Menopause 2023;30:1014-1021.

Amarh E, Tisdale JE, Overholser BR. Prolonged exposure to remdesivir inhibits the human ether-a-go-go-related gene potassium current. J Cardiovasc Pharmacol 2023;82:212-220.

Jentzer JC, Noseworthy PA, Kashou AH, May AM, Chrispin J, Kabra R, Arps K, Blumer V, Tisdale JE, Solomon MA. Multidisciplinary critical care management of electrical storm. J Am Coll Cardiol 2023;81:2189-2206.

Tan MS, Heise CW, Gallo T, Tisdale JE, Woosley RL, Antonescu CC, Gephart SM, Malone DC. Relationship between a risk score for QT interval prolongation and mortality across rural and urban inpatient facilities. J Electrocardiol 2023;77:4-9.

Carpenter JS, Cortés YI, Tisdale JE, Sheng Y, Jackson EA, Barinas-Mitchell E, Thurston RC. Palpitations across the menopause transition in SWAN: trajectories, characteristics and associations with subclinical cardiovascular disease. Menopause 2023;30:18-27.

Rowe EJ, Shugg T, Ly RC, Philips S, Rosenman MB, Callaghan JT, Radovich M, Overholser BR, Schneider BP, Tisdale JE, Skaar TC. Association of QT interval-prolonging drugs with clinical trial eligibility in patients with advanced cancer. Front Cardiovasc Med 2022;December 15: doi:.org/10.3389/fcvm.2022.894623.

Ueoka A, Sung YL, Liu X, Rosenberg C, Chen Z, Everett TH, Rubart M, Tisdale JE, Chen PS. Testosterone does not shorten action potential duration in Langendorff perfused rabbit ventricles. Heart Rhythm 2022;19:1864-1871.

Gallo T, Heise CW, Woosley RL, Tisdale JE, Antonescu CC, Gephart SM, Malone DC. Clinician satisfaction with advanced clinical decision support to reduce the risk of torsades de pointes. J Patient Saf 2022;18:e1010-e1013.

Carpenter JS, Sheng Y, Pike C, Elomba CD, Alwine JS, Chen CX, Tisdale JE. Correlates of palpitations during menopause: a scoping review. Women’s Health 2022;18:1-14.

Mar PL, Gopinathannair R, Gengler BE, Chung MK, Perez A, Dukes J, Ezekowitz MD, Lakkireddy D, Lip GYH, Miletello M, Noseworthy PA, Reiffel J, Tisdale JE, Olshansky B. Drug interactions affecting oral anticoagulant use. Circ Arrhythm Electrophysiol 2022;15:e007956.

Gallo T, Heise CW, Woosley RL, Tisdale JE, Tan MS, Gephart SM, Antonescu CC, Malone DC. Clinician responses to a clinical decision support advisory for high risk of torsades de pointes. J Am Heart Assoc 2022;June 7;11(11)11:e024338. doi: 10.1161/JAHA.122.024338

Mar PL, Horbal P, Chung MK, Dukes JW, Ezekowitz M, Lakkireddy D, Lip GYH, Miletello M, Noseworthy PA, Reiffel JA, Tisdale JE, Olshansky B, Gopinathannair R. Drug interactions affecting antiarrhythmic drug use. Circ Arrhythm Electrophysiol 2022;15:e007955.

Sheng Y, Carpenter JS, Elomba CD, Alwine JS, Yue M, Chen CX, Tisdale JE. Effect ofmenopausal symptom treatment options on palpitations: a systematic review. Climacteric 2022;25:128-140.

Carpenter JS, Tisdale JE, Larson JC, Sheng Y, Chen CX, Von Ah D, Kovacs R, Reed SD, Thurston RC, Guthrie KA. MsFLASH analysis of diurnal salivary cortisol and palpitations in peri- and postmenopausal women. Menopause2022;29;144-150.

Titus-Lay EN, Jaynes HA, Tomaselli Muensterman E, Ott CA, Walroth TA, Williams G, Moe PR, Wilbrandt M, Tisdale JE. Accuracy of a single-lead mobile smartphone electrocardiogram for QT interval measurement in patients undergoing maintenance methadone therapy. Pharmacotherapy 2021;41:494-500.

Muensterman ET, Jaynes HA, Sowinski KM, Overholser BR, Shen C, Kovacs RJ, Tisdale JE. Transdermal testosterone attenuates drug-induced lengthening of both early and late ventricular repolarization in older men. Clin Pharmacol Ther 2021;109:1499-1504.

Sheng Y, Carpenter JS, Elomba CD, Alwine JS, Yue M, Pike CA, Chen CX, Tisdale JE. Review of menopausal palpitations measures. Women’s Midlife Health 2021;7:5.

Carpenter JS, Tisdale JE, Chen CX, Kovacs R, Larson JC, Guthrie KA, Ensrud KE, Newton KM, LaCroix AZ. A Menopause Strategies-Finding Lasting Answers for Symptoms and Health (MsFLASH) investigation of self-reported menopausal palpitation distress. J Women’s Health 2021;30:533-538.

Titus-Lay EN, Jaynes HA, Muensterman ET, Walroth TA, Ott CA, Desta Z, Williams G, Moe PR, Wilbrandt M, Tisdale JE. Methadone-associated QT interval prolongation in patients undergoing maintenance therapy in an urban opioid treatment program. Pharmacotherapy 2021;41:238-246.

Carpenter JS, Sheng Y, Elomba CD, Alwine JS, Yue M, Pike CA, Chen CX, Tisdale JE. A systematic review of palpitations prevalence by menopausal status. Curr Obst Gyn Rep 2021;10:7-13.         

Tisdale JE, Chung MK, Campbell KB, Hammadah M, Joglar JA, Leclerc J, Rajagopalan B; on behalf of the American Heart Association Clinical Pharmacology Committee of the Council on Clinical Cardiology and Council on Cardiovascular and Stroke Nursing. Drug-induced arrhythmias: a Scientific Statement from the American Heart Association. Circulation 2020;142:e214-e233.

Tisdale JE, Jaynes HA, Overholser BR, Sowinski KM, Fisch MD, Rodgers JE, Aldemerdash A, Hsu C-C, Wang N, Muensterman ET, Rao V, Kovacs RJ. Enhanced response to drug-induced QT interval lengthening in patients with heart failure with preserved ejection fraction. J Cardiac Fail 2020;26:781-785.

Bauman JL, Tisdale JE. Chloroquine and hydroxychloroquine in the era of SARS – CoV2: caution on their cardiac toxicity. Pharmacotherapy 2020;40:387-388.

Shugg T, Egly C, Stamatkin CW, Patil AS, Tisdale JE, Overholser BR. Progesterone metabolites inhibit the human ether-a-go-go-related gene and predict QT interval length. J Clin Pharmacol 2020;60:648-659.

Gorenek B, Fisher JD, Kudaiberdieva G, Baranchuk A, Burri H, Campbell KB, Chung MK, Enriquez A, Heidbuchel H, Kutyifa V, Krishnan K, Leclercq C, Ozcan EE, Patton KK, Shen W, Tisdale JE, Turagam MK, Lakkireddy D. Premature ventricular complexes: diagnostic and therapeutic considerations in clinical practice. A state-of-the-art review by the American College of Cardiology Electrophysiology Council. J Interv Card Electrophysiol 2020;57:5-26.

Muensterman ET, Jaynes HA, Sowinski KM, Overholser BR, Shen C, Kovacs RJ, Tisdale JE. Effect of transdermal testosterone and oral progesterone on drug-induced QT interval lengthening in older men: a randomized, double-blind placebo-controlled crossover-design study. Circulation 2019;140:1127-1129.

Tisdale JE. Proarrhythmic food for thought. Heart Rhythm 2019;16:1149-1150.

Kovacs RJ, Birtcher KK, Tisdale JE. Pharmacists and cardiologists in the ACC. J Am Coll Cardiol 2019;74:470-472.

Zarowitz BJ, Tisdale JE. Navigating the minefield of QTc interval-prolonging therapy innursing facility residents. J Am Geriatr Soc 2019;67:1508-1515.

Tisdale JE, Jaynes HA, Watson MR, Corya AL, Shen C, Kesler KA. Amiodarone for prevention of atrial fibrillation following esophagectomy. J Thorac Cardiovasc Surg 2019;158:301-310.

Tisdale JE, Jaynes HA, Overholser BR, Sowinski KM, Kovacs RJ. Progesterone pretreatment reduces the incidence of drug-induced torsades de pointes in atrioventricular node-ablated isolated perfused rabbit hearts. J Cardiovasc Electrophysiol 2019;30:941-949.

Tisdale JE. Editorial commentary. Amiodarone-induced thyroid diseases: additional unintended consequences. Trends Cardiovasc Med 2019;29:296-297.

Tomaselli Muensterman E, Tisdale JE. Predictive analytics for identification of patients at risk for QT interval prolongation: a systematic review. Pharmacotherapy 2018;38:813-821. 

Ko J-S, Guo S, Hassel J, Celestino-Soper P, Lynnes TC, Tisdale JE, Zheng JJ, Taylor SE, Foroud T, Murray MD, Kovacs RJ, Li X, Lin S-F, Chen Z, Vatta M, Chen P-S, Rubart M. Ondansetron blocks wild-type and p.F503L variant small-conductance Ca²⁺- activated K⁺ channels. Am J Physiol Heart Circ Physiol 2018;315:H375-H388

Tisdale JE. Research conducted by hospital pharmacists: an integral component of daily practice or unrealistic expectation? Can J Hosp Pharm 2018;71:95-96.

Alburikan KA, Aldemerdash A, Savitz ST, Tisdale JE, Whitsel EA, Soliman EZ, Thudium EM, Sueta CA, Kucharska-Newton AM, Stearns SC, Rodgers JE. Contributions of medications and risk factors to QTc interval lengthening in the atherosclerosis risk in communities (ARIC) Study. J Eval Clin Pract 2017;23:1274-1280.

Tisdale JE. Editorial commentary: Optimization of dose selection for non-vitamin K antagonist oral anticoagulants. Trends Cardiovasc Med 2017;27:573-574.

Tisdale JE. Prevalence and significance of acquired QT interval prolongation in hospitalized patients. Heart Rhythm2017;14:979-980.

Tisdale JE, Jaynes HA, Overholser BR, Sowinski KM, Flockhart DA, Kovacs RJ. Influence of oral progesterone administration on drug-induced QT interval lengthening. A randomized, placebo-controlled crossover trial. JACC Clin Electrophysiol 2016;2:765-774.

Melton BL, Zillich AJ, Saleem J, Russ AL, Tisdale JE, Overholser BR. Iterative development and evaluation of a pharmacogenomic-guided clinical decision support system for warfarin dosing. Appl Clin Inform 2016;7:1088-1106.

Abdelhady AM, Shugg T, Thong N, Lu JB, Kreutz Y, Jaynes HA, Robarge JD, Tisdale JE, Desta Z, Overholser BR. Efavirenz inhibits the human ether-a-go-go related current (hERG) and induces QT interval prolongation in CYP2B6*6*6allele carriers. J Cardiovasc Electrophysiol 2016;27:1206-1213.  

Tisdale JE. Drug-induced QT interval prolongation and torsades de pointes – role of the pharmacist in risk assessment, prevention and management. Can Pharm J 2016;149:139-152.

Tisdale JE. Drug-induced QT interval prolongation in children – are the kids alright? Can J Hosp Pharm 2016;69:183-184.

Tisdale JE, Allen MR, Overholser BR, Jaynes HA, Kovacs RJ. Influence of zoledronic acid on atrial electrophysiological parameters and electrocardiographic measurements.  J Cardiovasc Electrophysiol 2015;26:671-677.

Frendl G, Sodickson AC, Chung MK, Waldo AL, Gersh BJ, Tisdale JE, Calkins H, Aranki S, Kaneko T, Cassivi S, Smith SC Jr, Darbar D, Wee JO, Waddell TK, Amar D, Adler D. 2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures. J Thorac Cardiovasc Surg 2014;148:e153-193.

Frendl G, Sodickson AC, Chung MK, Waldo AL, Gersh BJ, Tisdale JE, Calkins H, Aranki S, Kaneko T, Cassivi S, Smith SC Jr, Darbar D, Wee JO, Waddell TK, Amar D, Adler D. 2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures. Executive summary. J Thorac Cardiovasc Surg 2014;148:772-791.

Tisdale JE. What causes some patients with drug-induced QT interval prolongation to develop torsades de pointes but not others? The elusive missing link. Drugs Aging 2014;31:577-579.

Tisdale JE. Can I get a guideline to help me interpret treatment guidelines? Can J Hosp Pharm 2014;67:181-182.

Tisdale JE, Jaynes HA, Kingery JR, Overholser BR, Mourad NA, Trujillo TN, Kovacs RJ. Effectiveness of a clinical decision support system for reducing the risk of QT interval prolongation in hospitalized patients. Circ Cardiovasc Qual Outcomes 2014;7:381-390.

Trinkley KE, Page II RL, Lien H, Yamanouye K, Tisdale JE. QT interval prolongation and the risk of torsades de pointes: essentials for clinicians. Curr Med Res Opin 2013;29:1729-1736.

Tisdale JE, Jaynes HA, Kingery JR, Mourad NA, Trujillo TN, Overholser BR, KovacsRJ. Development and validation of a risk score to predict QT interval prolongation inhospitalized patients. Circ Cardiovasc Qual Outcomes 2013;6:479-487.

Mohamed AN, Abdelhady AM, Spencer D, Sowinski KM, Tisdale JE, Overholser BR. Pharmacokinetic modeling and simulation of procainamide and N-acetylprocainamide in apatient receiving continuous renal replacement therapy: a novel approach to guide renal dose adjustments. Am J Kidney Dis 2013;61:1046-1048.

Tisdale JE, Overholser BR, Sowinski KM, Wroblewski HA, Amankwa K, Borzak S, Coram R, Kingery J, Zipes DM, Flockhart DA, Kovacs RJ. Enhanced sensitivity to drug-induced QT interval lengthening in patients with heart failure due to left ventricular systolic dysfunction. J Clin Pharmacol 2012;52:1296-1305.

Tisdale JE, Hall KW. Hospital pharmacy in Canada. Ahead of the curve. Can J Hosp Pharm 2012;65:345-346.

Kaakeh Y, Overholser BR, Lopshire J, Tisdale JE. Drug-induced atrial fibrillation. Drugs 2012;72:1617-1630.

Hall KW, Musing E, Miller DA, Tisdale JE. Experiential training for pharmacy students: time for a new approach. Can J Hosp Pharm 2012;65:285-293

Wroblewski HA, Kovacs RJ, Kingery JR, Overholser BR, Tisdale JE. High risk of QT interval prolongation and torsades de pointes associated with intravenous quinidine used for the treatment of resistant malaria or babesiosis. Antimicrob Agents Chemother 2012;56:4495-4499.

Tisdale JE, Wroblewski HA, Overholser BR, Kingery JR, Trujillo TN, Kovacs RJ. Prevalence of QT interval prolongation in patients admitted to cardiac care units and frequency of subsequent administration of QT interval-prolonging drugs. A prospective, observational study in a large urban academic medical center in the US. Drug Saf2012;35:459-470.

Fernando HC, Jaklitsch MT, Walsh GL, Tisdale JE, Bridges CD, Mitchell JD, Shrager JB. The Society of Thoracic Surgeons practice guideline on the prophylaxis and management of atrial fibrillation associated with general thoracic surgery: executive summary. Ann Thorac Surg 2011;92:1144-52.

Tisdale JE, Overholser BR, Wroblewski HA, Sowinski KM. The influence of progesterone alone and in combination with estradiol on ventricular action potential duration and triangulation in response to potassium channel inhibition. J Cardiovasc Electrophysiol 2011;22:325-331.

Tisdale JE. Toward a unified model for contemporary institutional pharmacy practice. Can J Hosp Pharm 2011;64:97-99.

Tisdale JE, Wroblewski HA, Kesler KA. Prophylaxis of atrial fibrillation after noncardiacthoracic surgery. Semin Thorac Cardiovasc Surg 2010;22:310-320.

Tisdale JE, Wroblewski HA, Wall DS, Rieger KM, Hammoud ZT, Young JV, Kesler KA. A randomized, controlled study of amiodarone for prevention of atrial fibrillation after transthoracic esophagectomy. J Thorac Cardiovasc Surg2010;140:45-51.

Tisdale JE. Integrity in authorship and publication. Can J Hosp Pharm 2009;62:441-442.

Overholser BR, Zheng X, Tisdale JE. Paroxysmal β-adrenergic receptor mediatedalterations in ventricular repolarization at rapid heart rates during inhibition of delayed rectifier currents. J Cardiovasc Pharmacol 2009;54:253-262.

Tisdale JE, Wroblewski HA, Wall DS, Rieger KM, Hammoud ZT, Young JV, Kesler KA. A randomized trial evaluating amiodarone for prevention of atrial fibrillation after pulmonary resection. Ann Thorac Surg 2009;88:886-895.

Tisdale JE, Overholser BR, Sowinski KM, Wroblewski HA, Amankwa K, Borzak S, Coram R, Kingery J, Zipes DM, Flockhart DA, Kovacs RJ. Pharmacokinetics of ibutilide in patients with heart failure due to left ventricular systolic dysfunction. Pharmacotherapy 2008;28:1461-1470.

Tisdale JE. Medication reconciliation – who, and how? Can J Hosp Pharm 2008;61:241-242.

Overholser BR, Zheng X, Tisdale JE. Catecholaminergic effects on ventricular repolarization during inhibition of the rapid component of the delayed rectifier potassium current in a perfused heart model. Pharmacotherapy2008;28:1315-1324.

Dopp AL, Miller JM, Tisdale JE. Effect of drugs on defibrillation capacity. Drugs 2008;68:607-630

Tisdale JE, Wroblewski HA, Hammoud ZT, Rieger KM, Young JV, Wall DS, Kesler KA. Prospective evaluation of serum amiodarone concentrations when administered via anasogastric tube into the stomach conduit after transthoracic esophagectomy. Clin Ther 2007;29:2226-34.

Buckley MS, Nolan PE Jr, Slack MK, Tisdale JE, Hilleman DE, Copeland JG. Amiodarone prophylaxis for atrial fibrillation after cardiac surgery: meta-analysis of dose response and timing of initiation. Pharmacotherapy 2007;27:360-368.

Tisdale JE, Kovacs R, Mi D, McCabe GP, Cariera BL, Sharma N, Rosman H. Accuracy of uncorrected versus corrected QT interval for prediction of torsades de pointes associated with intravenous haloperidol. Pharmacotherapy 2007;27:175-82.

Tisdale JE. Pharmacist? What pharmacist? Can J Hosp Pharm 2006;59:235-236. 

Tisdale JE, Borzak S, Goldstein S, Shimoyama H, Sabbah HN. Hemodynamic and neurohormonal predictors and consequences of the development of atrial fibrillation in dogs with chronic heart failure. J Cardiac Fail 2006;12:747-51.

Dager WE, Sanoski C, Wiggins B, Tisdale JE. Pharmacotherapy considerations in advanced cardiac life support. Pharmacotherapy 2006;26:1703-1729.

Tisdale JE. Role of the pharmacist in managing hypertension in patients with diabetes.Am J Health-Sys Pharm 2006;63:1129.

Tisdale JE, Huang MB, Borzak S. Risk factors for hypertensive crisis: importance ofout-patient blood pressure control. Fam Pract 2004;21:420-424.

Rasty S, Amin NB, Sabbah HN, Mishima T, Borzak S, Tisdale JE. Influence of IV haloperidol on ventricular repolarization and monophasic action potential duration in anesthetized dogs. Chest 2004;125:1821-1829.

Amankwa K, Krishnan CK, Tisdale JE. Torsades de pointes associated with fluoroquinolones. Importance of concomitant risk factors. Clin Pharmacol Ther 2004;75:242-7.

Tisdale JE. Indexing of journals in MEDLINE, PubMed and other bibliographic databases – why not CJHP? Can J Hosp Pharm 2004;57:77-78.

Rasty S, Borzak S, Tisdale JE. Bleeding associated with eptifibatide targeting higher-risk patients: incidence and multivariate risk factors. J Clin Pharmacol 2002;42:1366-1373

Tisdale JE. Teaching and mentorship – invaluable contributions to the profession. Can J Hosp Pharm 2002:55;192-194.

Tisdale JE, Rasty S, Padhi ID, Sharma N, Rosman H. The effect of intravenous haloperidol on QT interval dispersion in critically ill patients: comparison with QT interval prolongation for assessment of risk of Torsades de Pointes. J Clin Pharmacol 2001;41:1310-1318. 

Tran AH, Yrigoyen LG, Racine E, Tisdale JE. Use of dofetilide in atrial fibrillation and atrial flutter. J Am Pharm Assoc 2001;41:747-759.

Slavik RS, Tisdale JE, Borzak S. Pharmacological conversion of atrial fibrillation: a systematic review of available evidence. Prog Cardiovasc Dis 2001;44:121-152.

Moser LR, Tisdale JE, Smythe MA. Calcium pretreatment for prevention of hypotension associated with intravenous calcium channel blockers. Ann Pharmacother 2000;34:622-629.

Tisdale JE. Drug-related problems: much ado about something. Can J Hosp Pharm 2000;53:314-316.

Zed P, Tisdale JE, Borzak S.  Low molecular weight heparins in acute coronary syndromes. Arch Intern Med1999;159:1849-1857.

Tisdale JE. Antiplatelet therapy in coronary artery disease: Review and update of efficacy studies. Am J Health-Syst Pharm 1998;55:S8-S16.

Amin N, Borzak S, Housholder SA, Tisdale JE. Multiple episodes of sinus arrest following the administration of ibutilide in a patient with underlying sinus node dysfunction. Heart 1998;79:628-9.

Borzak S, Tisdale JE, Amin NB, Goldberg AD, Frank D, Padhi ID, Higgins RSD. Atrial fibrillation after bypass surgery. Does the arrhythmia or the characteristics of the patients prolong hospital stay? Chest 1998;113:1489-1491

Tisdale JE, Padhi ID, Goldberg AD, Silverman NA, Webb CR, Higgins RS, Paone G, Frank DM, Borzak S. A randomized, double-blind comparison of intravenous diltiazem and digoxin for atrial fibrillation after coronary artery bypass surgery. Am Heart J 1998;135:739-747.

Sharma ND, Rosman HS, Padhi ID, Tisdale JE. Torsades de pointes associated with intravenous haloperidol in critically ill patients. Am J Cardiol 1998;81:238-240.

Tisdale JE, Padhi ID, Ware JA, Svensson CK. Comparison of fluorescence polarizationimmunoassay with liquid chromatography for quantification of procainamide and N-acetylprocainamide in urine. Ther Drug Monit 1996;18:693-697.

Tisdale JE, Ducharme MP, Shimoyama H, Webb CR, Sabbah HN, Edwards DJ. Electrophysiologic and electrocardiographic pharmacodynamics of cocaine. Pharmacotherapy 1996;16:438-445.

Tisdale JE, Shimoyama H, Sabbah HN, Webb CR. The effect of cocaine on ventricular fibrillation threshold in the normal canine heart.  Pharmacotherapy 1996;16:429-37.

Tisdale JE, Sun H, Zhao H, Fan C, Colucci RD, Kluger J, Chow MSS. Antifibrillatoryeffect of esmolol alone and in combination with lidocaine. J Cardiovasc Pharmacol 1996; 27:376-382.

Tisdale JE, Rudis MI, Padhi ID, Borzak S, Svensson CK, Webb CR, Acciaioli J, Ware JA, Krepostman A, Zarowitz BJ. Disposition of procainamide in patients with chronic congestive heart failure receiving medical therapy. J Clin Pharmacol1996;36:35-41.

Tisdale JE, Rudis MI, Padhi ID, Svensson CK, Webb CR, Borzak S, Ware JA, Krepostman A, Zarowitz BJ. Inhibition of N-acetylation of procainamide and renal clearance of N-acetylprocainamide by para-aminobenzoic acid in humans. J Clin Pharmacol 1995;35:902-910.

Tisdale JE, Patel R, Borzak S, Webb CR, Zarowitz BJ. Electrophysiologic and proarrhythmic effects of intravenous inotropic agents. Prog Cardiovasc Dis 1995;38:167-180.

Tisdale JE, Follin SL, Ordelova A, Webb CR. Risk factors for the development ofspecific noncardiovascular adverse effects associated with amiodarone. J Clin Pharmacol 1995; 35:351-356.

Tisdale JE, Patel R, Borzak S, Webb CR, Zarowitz BJ.  Proarrhythmic effects of intravenous vasopressors. Ann Pharmacother 1995;29:269-281.

Fan C, Tisdale JE, Ujhelyi MR, Chow MSS. Accuracy of unbound-quinidine concentration determination after ultrafiltration. Clin Pharm 1993;12:917-921

Tisdale JE, Kluger J, Fisher JR, Chow MSS.  Efficacy of class 1C antiarrhythmic agentsin patients with inducible ventricular tachycardia refractory to class 1A antiarrhythmic drugs. J Clin Pharmacol 1993;33:623-630.

Tisdale JE, Colucci RD, Ujhelyi MR, Kluger J, Fieldman A, Chow MSS. Evaluation and comparison of the adverse effects of streptokinase and alteplase. Pharmacotherapy 1992;12:440-444.

Tisdale JE, Tsuyuki RT, Oles KS, Penry JK. Relationship between serum concentrationand dose of valproic acid during monotherapy in adult outpatients. Ther Drug Monit 1992;14:416-423.

Tisdale JE, Webb CR. Are antiarrhythmic drugs obsolete? Clin Pharm 1992;11:714-726.

Tisdale JE, Gheorghiade M. Acute hemodynamic effects of digoxin alone or in combination with other vasoactive agents in patients with heart failure. Am J Cardiol 1992;69:34G-47G.